According to Ultragenyx Pharmaceutical's latest financial reports the company's current earnings are โน0.63 Billion. In 2024 the company made an earning of -โน45.57 Billion, an increase over its 2023 earnings that were of -โน48.99 Billion. The earnings displayed on this page is the company's Pretax Income.